Angiotensin II signaling in vascular smooth muscle: New concepts

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 366-373

  Griendling, Kathy K ^a   Ushio Fukai, Masuko ^a   Lassègue, Bernard ^a   Alexander, R Wayne ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin II; oxidant stress; phospholipase; phosphorylation; receptor sequestration; tyrosine; vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CYTOKINE RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE C; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; RAS PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR;

ARTICLE; CELL GROWTH; ENZYME ACTIVATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

EID: 85026152850     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.366     Document Type: Article

References (86)

1. Elliott DF, Peart WS. Amino acid sequence of a hypertensin. Nature. 1956;177:527-528.
2. Geisterfer A, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
3. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
4. Campbell-Boswell M, Robertson A. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol. 1981;35:265-276.
5. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells: role of cyclic nucleotides and angiotensin-1 receptors. J Clin Invest. 1995; 96:141-149.
6. Kato H, Suzuki H, Tajima S, et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
7. Sasaki K, Yamano Y, Bardhan S, et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
8. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
9. Alexander RW, Brock TA, Gimbrone MA Jr, Rittenhouse SE. Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension. 1985;7:447-451.
10. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr, Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem. 1986;261:5901-5906.
11. Brock TA, Rittenhouse SE, Powers CW, Ekstein LS, Gimbrone MA Jr, Alexander RW. Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem. 1985;260:14158-14162.
12. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J Biol Chem. 1994; 269:10935-10939.
13. Socorro L, Alexander RW, Griendling KK. Cholera toxin modulation of angiotensin II-stimulated inositol phosphate production in cultured vascular smooth muscle cells. Biochem J. 1990;265:799-807.
14. 11 α-subunits in cultured vascular smooth muscle cells. Mol Pharmacol. 1996;49:96-104.
15. Homma Y, Sakamoto H, Tsunoda M, Aoki M, Takenawa T, Ooyama T. Evidence for involvement of phospholipase C-gamma 2 in signal transduction of platelet-derived growth factor in vascular smooth muscle cells. Biochem J. 1993;290:649-653.
16. Lassègue B, Alexander RW, Clark M, Akers MA, Griendling KK. Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth muscle cells. Biochem J. 1993;292:509-517.
17. Exton J. Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta. 1994;1212:26-42.
18. Hammond SM, Altshuller YM, Sung T-C, et al. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem. 1995;270:29640-29643.
19. Kondo T, Inui H, Konishi F, Inagami T. Phospholipase D mimics platelet-derived growth factor as a competence factor in vascular smooth muscle cells. J Biol Chem. 1992;267:23609-23616.
20. Bellavite P, Corso F, Dusi S, Grzeskowiak M, Della-Bianca V, Rossi F. Activation of NADPH-dependent superoxide production in plasma membrane extracts of pig neutrophils by phosphatidic acid. J Biol Chem. 1988;263:8210-8214.
21. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
22. Rao GN, Lassegue B, Alexander RW, Griendling KK. Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem J. 1994; 299:197-201.
23. Natarajan R, Gonzales N, Hornsby PJ, Nadler J. Mechanisms of angiotensin II-induced proliferation in bovine adrenocortical cells. Endocrinology. 1992;131:1174-1180.
24. Zafari AM, Alexander RW, Minieri C, Akers M, Lassègue B, Griendling KK. Arachidonic acid metabolites mediate angiotensin II-induced hypertrophy by stimulation of NADH/NADPH oxidase activity in cultured vascular smooth muscle cells. FASEB J. 1996; 10:A1013. Abstract.
25. Tsuda T, Kawahara Y, Shii K, Koide M, Ishida Y, Yokoyama M. Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett. 1991;285:44-48.
26. Du J, Sperling LS, Marrero MB, Phillips L, Delafontaine P. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem Biophys Res Commun. 1996;218:934-939.
27. Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem. 1995;270:12563-12568.
28. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res. 1995;77:1053-1059.
29. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993;268:7338-7345.
30. Butcher RD, Schöllmann C, Marmé D. Angiotensin II mediates intracellular signaling in vascular smooth muscle cells by activation of tyrosine-specific kinases and c-raf-1. Biochem Biophys Res Commun. 1993;196:1280-1287.
31. Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem. 1994;269:19626-19632.
32. Leduc I, Meloche S. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem. 1995;270:4401-4404.
33. Akiho H, Tokumitsu Y, Noda M, Nomura Y. Decreases in coupling of Gs in v-src transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src. Arch Biochem Biophys. 1993;304:235-241.
34. Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases: the alpha-isoform of caveolin is selectively phosphorylated by v-src in vivo. J Biol Chem. 1996;271:3863-3868.
35. Marrero MB, Schieffer B, Paxton WG, Schieffer E, Bernstein KE. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-γ1 in rat aortic smooth muscle cells. J Biol Chem. 1995;270:15734-15738.
36. Schieffer B, Paxton WG, Marrero MB, Bernstein KE. Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling. Hypertension. 1996;27:476-480.
37. Touhara K, Hawes BE, Van Biesen T, Lefkowitz RJ. G protein βγ subunits stimulate phosphorylation of she adapter protein. Proc Natl Acad Sci U S A. 1995;92:9284-9287.
38. Pronk GJ, de Vries-Smits AMM, Buday L, et al. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras. Mol Cell Biol. 1994;14:1575-1581.
39. Marrero MB, Schieffer B, Paxton WG, et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.
40. Schaller MD, Parsons JT. Focal adhesion kinase: an integrin linked protein tyrosine kinase. Trends Cell Biol. 1993;3:258-261.
41. Turner CE, Pietras KM, Taylor DS, Molloy CJ. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci. 1995;108:333-342.
42. Boulton TG, Nye SH, Robbins DJ, et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 1991;65:663-675.
43. Payne DM, Rossomando AJ, Martino P, et al. Identification of the regulatory phosphorylation sites in pp42/mitogen activated protein kinase (MAP kinase). EMBO J. 1991;10:885-892.
44. Duff JL, Marrero MB, Paxton WG, Schieffer B, Bernstein KE, Berk BC. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovas Res. 1995;30:511-517.
45. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama M. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res. 1992;71:620-630.
46. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188: 257-264.
47. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J Biol Chem. 1996;271:14169-14175.
48. Crews CM, Alessandrini A, Erickson RL. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 1992;258:478-480.
49. Davis RJ. Transcriptional regulation by MAP kinases. Mol Reprod Dev. 1995;42:459-467.
50. Ishida Y, Kawahara Y, Tsuda T, Yokoyama M. Involvement of MAP kinase activators in angiotensin II-induced activation of MAP kinases in cultured vascular smooth muscle cells. FEBS Lett. 1992;310:41-45.
51. Leevers SJ, Paterson HF, Marshall CJ. Requirement for ras in raf activation is overcome by targeting raf to the plasma membrane. Nature. 1994;369:411-414.
52. Lowenstein EJ, Daly RJ, Betzer AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70:431-442.
53. van Biesen T, Hawes BE, Luttrell DK, et al. Receptor-tyrosine-kinase- and Gbg-mediated MAP kinase activation by a common signaling pathway. Nature. 1995;376:781-784.
54. Wan Y, Kurosaki T, Huang X-Y. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature. 1996;380:541-544.
55. Hawes BE, Luttrell LM, van Biesen T, Lefkowitz RJ. Phosphatidylinositol 3-kinase is an early intermediate in the Gbg-mediated mitogen activated protein kinase signaling pathway. J Biol Chem. 1996;271:12133-12136.
56. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an early immediate gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993;75:487-493.
57. Duff JL, Monia BP, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J Biol Chem. 1995;270:7161-7166.
58. Duff JL, Marrero MB, Paxton WG, et al. Angiotensin II induces 3CH134, a protein tyrosine phosphatase, in vascular smooth muscle cells. J Biol Chem. 1993;268:26037-26040.
59. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 1993;262:1065-1069.
60. Cook SJ, McCormick F. Inhibition by cAMP of ras-dependent activation of raf. Science. 1993;262:1069-1072.
61. Pfeilschifter J, Bauer C. Different effects of phorbol ester on angiotensin II- and stable GTP analogue-induced activation of polyphosphoinositide phosphodiesterase in membranes isolated from rat renal mesangial cells. Biochem J. 1987;248:209-215.
62. Lefkowitz RJ. G-protein coupled receptor kinases. Cell 1993;74: 409-412.
63. Kai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW. Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension. 1994;24:523-527.
64. Oppermann M, Freedman NJ, Alexander RW, Lefkowitz RJ. Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem. 1996; 271:13266-13272.
65. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MA Jr, Alexander RW. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem. 1987;262:14555-14562.
66. Peach MJ. Molecular actions of angiotensin. Biochem Pharmacol. 1981;30:2745-2751.
67. Anderson KM, Murahashi T, Dostal DE, Peach MJ. Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am J Physiol. 1993;264:C179-C188.
68. Zhang J, Ferguson SSG, Barak LS, Ménard L, Caron MG. Dynamin and beta-arrestin reveal distinct mechanisms for G-protein coupled receptor internalization. J Biol Chem. 1996;271:18302-18305.
69. Liu P, Ying Y, Ko Y, Anderson RGW. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem. 1996;271:10299-10303.
70. Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae. J Cell Biol. 1994;126:353-363.
71. Jones OTG. The regulation of superoxide production by the NADPH oxidase of neutrophils and other mammalian cells. Bioessays. 1994; 16:919-923.
72. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271: 23317-23321.
73. Mohazzab KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol. 1994;267:L815-L822.
74. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
75. Rao GN, Runge MS, Alexander RW. Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta. 1995;1265:67-72.
76. - in vascular smooth muscle cells. Circ Res. 1995;77:29-36.
77. Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates ras and extracellular signal-regulated protein kinases group of mitogen activated protein kinases. Oncogene. 1996;13:713-719.
78. Rao GN, Lassegue B, Griendling KK, Alexander RW, Berk BC. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucleic Acids Res. 1993;21: 1259-1263.
79. Rao GN, Lassegue B, Griendling KK, Alexander RW. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidȯnic acid. Oncogene. 1993;8:2759-2764.
80. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth-and proto-oncogene expression. Circ Res. 1992; 70:593-599.
81. Tsai J-C, Jain M, Hsieh C-M, et al. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 1996;271:3667-3670.
82. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57:313-370.
83. 1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601-609.
84. Ishizaka N, Griendling KK, Fukui T, Oppermann M, Lefkowitz RJ, Alexander RW. Functional interaction between angiotensin II and GRK5 in cultured vascular smooth muscle cells (VSMC) and rat aorta. FASEB J. 1996;10 A1134. Abstract.
85. Paxton WG, Marrero MB, Klein JD, Delafontaine P, Berk BC, Bernstein KE. The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem Biophys Res Commun. 1994;200:260-267.
86. Polte TR, Naftilan AJ, Hanks SK. Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II. J Cell Biochem. 1994;55:106-119.